George Fennell, Executive Vice President of IDEXX Laboratories ($IDXX), sold about $7.3 million in company shares through eight open market transactions over the past year. His most recent sale occurred on February 10, 2026. These sales rank him 1443rd among 11,678 insiders by total value sold, below the average of $8.6 million per insider and 6.4 transactions. Fennell made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 55 | $0.00 | 9,878.0000 | 81,025,000 | 0.56% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 204 | $0.00 | 612.0000 | 81,025,000 | 25.00% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 139 | $0.00 | 278.0000 | 81,025,000 | 33.33% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 56 | $0.00 | 56.0000 | 81,025,000 | 50.00% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 55 | $0.00 | 0.0000 | 81,025,000 | 100.00% | 0.00% |
| Feb. 12, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | A | Restricted Stock Unit | 810 | $0.00 | 810.0000 | 81,025,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | A | Incentive Stock Option (right-to-buy) | 162 | $0.00 | 162.0000 | 81,025,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | A | Non-Qualified Stock Option (right-to-buy) | 3384 | $0.00 | 3,384.0000 | 81,025,000 | 9999.99% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | F | Common Stock | 199 | $629.35 | 10,078.0000 | 81,025,000 | 1.94% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 204 | $0.00 | 10,277.0000 | 81,025,000 | 2.03% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 139 | $0.00 | 10,073.0000 | 81,025,000 | 1.40% | 0.00% |
| Feb. 14, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 56 | $0.00 | 9,934.0000 | 81,025,000 | 0.57% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Non-Qualified Stock Option (right-to-buy) | 11345 | $0.00 | 0.0000 | 81,025,000 | 100.00% | 0.01% |
| Feb. 9, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Incentive Stock Option (right-to-buy) | 1476 | $0.00 | 0.0000 | 81,025,000 | 100.00% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 40 | $650.32 | 9,823.0000 | 81,025,000 | 0.41% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 2809 | $649.26 | 9,863.0000 | 81,025,000 | 22.17% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 966 | $648.78 | 12,672.0000 | 81,025,000 | 7.08% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 1060 | $647.21 | 13,638.0000 | 81,025,000 | 7.21% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 2782 | $646.23 | 14,698.0000 | 81,025,000 | 15.92% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 2161 | $645.25 | 17,480.0000 | 81,025,000 | 11.00% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 397 | $644.02 | 19,641.0000 | 81,025,000 | 1.98% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 1130 | $643.00 | 20,038.0000 | 81,025,000 | 5.34% | 0.00% |
| Feb. 10, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 11345 | $67.85 | 21,168.0000 | 81,025,000 | 115.49% | 0.01% |
| Feb. 9, 2026 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 1476 | $67.85 | 9,823.0000 | 81,025,000 | 17.68% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 51 | $0.00 | 8,227.0000 | 83,246,000 | 0.62% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 56 | $0.00 | 8,283.0000 | 83,246,000 | 0.68% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 57 | $0.00 | 8,340.0000 | 83,246,000 | 0.69% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 140 | $0.00 | 8,480.0000 | 83,246,000 | 1.68% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | F | Common Stock | 133 | $444.53 | 8,347.0000 | 83,246,000 | 1.57% | 0.00% |
| Feb. 13, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | A | Non-Qualified Stock Option (right-to-buy) | 3415 | $0.00 | 3,415.0000 | 83,246,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | A | Incentive Stock Option (right-to-buy) | 217 | $0.00 | 217.0000 | 83,246,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | A | Restricted Stock Unit | 816 | $0.00 | 816.0000 | 83,246,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 51 | $0.00 | 0.0000 | 83,246,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 56 | $0.00 | 55.0000 | 83,246,000 | 50.45% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 57 | $0.00 | 112.0000 | 83,246,000 | 33.73% | 0.00% |
| Feb. 14, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Restricted Stock Unit | 140 | $0.00 | 417.0000 | 83,246,000 | 25.13% | 0.00% |
| Feb. 10, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Non-Qualified Stock Option (right-to-buy) | 9986 | $0.00 | 0.0000 | 83,246,000 | 100.00% | 0.01% |
| Feb. 7, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 1256 | $79.54 | 8,176.0000 | 83,246,000 | 18.15% | 0.00% |
| Feb. 10, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Common Stock | 9986 | $79.54 | 18,162.0000 | 83,246,000 | 122.14% | 0.01% |
| Feb. 10, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | S | Common Stock | 9986 | $462.53 | 8,176.0000 | 83,246,000 | 54.98% | 0.01% |
| Feb. 7, 2025 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | Executive Vice President | M | Incentive Stock Option (right-to-buy) | 1256 | $0.00 | 0.0000 | 83,246,000 | 100.00% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | A | Restricted Stock Unit | 557 | $0.00 | 557.0000 | 83,978,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Restricted Stock Unit | 108 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | A | Incentive Stock Option (right-to-buy) | 178 | $0.00 | 178.0000 | 83,978,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | A | Non-Qualified Stock Option (right-to-buy) | 2408 | $0.00 | 2,408.0000 | 83,978,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | F | Common Stock | 162 | $560.56 | 6,920.0000 | 83,978,000 | 2.29% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 57 | $0.00 | 7,082.0000 | 83,978,000 | 0.81% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 56 | $0.00 | 7,025.0000 | 83,978,000 | 0.80% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 52 | $0.00 | 6,969.0000 | 83,978,000 | 0.75% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 97 | $0.00 | 6,917.0000 | 83,978,000 | 1.42% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 108 | $0.00 | 6,820.0000 | 83,978,000 | 1.61% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Restricted Stock Unit | 57 | $0.00 | 169.0000 | 83,978,000 | 25.22% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Restricted Stock Unit | 56 | $0.00 | 111.0000 | 83,978,000 | 33.53% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Restricted Stock Unit | 52 | $0.00 | 51.0000 | 83,978,000 | 50.49% | 0.00% |
| Feb. 14, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Restricted Stock Unit | 97 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | S | Common Stock | 1209 | $572.14 | 13,701.0000 | 83,978,000 | 8.11% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 8198 | $62.00 | 14,910.0000 | 83,978,000 | 122.14% | 0.01% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Common Stock | 1612 | $62.00 | 6,712.0000 | 83,978,000 | 31.61% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Non-Qualified Stock Option (right-to-buy) | 8198 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.01% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | M | Incentive Stock Option (right-to-buy) | 1612 | $0.00 | 0.0000 | 83,978,000 | 100.00% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | S | Common Stock | 412 | $575.80 | 6,712.0000 | 83,978,000 | 5.78% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | S | Common Stock | 2279 | $572.78 | 11,422.0000 | 83,978,000 | 16.63% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | S | Common Stock | 1125 | $573.98 | 10,297.0000 | 83,978,000 | 9.85% | 0.00% |
| Feb. 8, 2024 | IDEXX LABORATORIES INC /DE | $IDXX | FENNELL GEORGE | SVP, Chief Revenue Officer | S | Common Stock | 3173 | $575.02 | 7,124.0000 | 83,978,000 | 30.81% | 0.00% |